— Quality Assurance
Our quality system is built on three pillars: prevention, in-process control, and final batch release — backed by full documentation.
At Global Pharmaceutical, quality is not a department — it is a discipline shared by every operator, technician, pharmacist and analyst on our team. From sourcing of raw materials to release of finished goods, every stage is documented, traceable and reviewed.
Our analytical laboratory runs identification, assay, dissolution, microbial and stability tests using calibrated, internationally recognised methods.
— Standards
Certificate LMHRA/GMP/23-0001 for tablets, capsules and powder for sachets.
Independent in-house quality assurance signs off every production batch.
Certified by Integral Certification Ltd. for quality, environmental and occupational health & safety management.
Stability and potency testing on all finished products.
Fully equipped QC laboratory for chemical and microbiological analysis.
Finished products analysed against USP-NF monographs by ISO/IEC 17025 accredited USP-Ghana.
The framework above describes our internal quality system. Every certification document below is published exactly as issued by the certifying authority.
— Documents
— Licences & agreements
Original documents are held on file at our Monrovia head office and can be shared with partners and regulators on request.
Republic of Liberia
Ratified 2023 · 15-year term
Global Pharmaceutical Manufacturing & Laboratories Ltd. has successfully secured a Concession Agreement with the Republic of Liberia in 2023.
Global Pharmaceutical presented its bill to the Lower House in 2022. The bill was approved and ratified by the Honourable Lower House and the Honourable House of Senate, then signed and approved by the President of the Republic of Liberia — making it an act granting us a 15-year concession agreement.
This was the first and only agreement of its kind between the Republic of Liberia and a pharmaceutical or medical company granted for 15 years.
Liberia Medicines & Health Products Regulatory Authority (LMHRA)
LMHRA/GMP/23-0001 · issued 21 February 2023
Following LMHRA inspections of our Monrovia facility, Global Pharmaceutical was awarded a WHO-format Certificate of Good Manufacturing Practice.
The certificate covers non-sterile tablets, capsules and powder for sachets, including manufacturing, quality control testing, packaging and batch release.
Liberia Medicines & Health Products Regulatory Authority (LMHRA)
LMHRA/ML/23-0001 · Section IV A · valid to 20 February 2028
Global Pharmaceutical holds a full LMHRA manufacturing licence authorising the manufacture of medicines for human use at Caldwell Road, Township of Caldwell, Bushrod Island, Monrovia.
The licence is issued under the LMHRA Act and is subject to the regulations and conditions promulgated thereunder.
LMHRA Inspector General Office · analysis by USP-Ghana, Accra
RL/LMHRA/INSP/1253/22 · issued 20 January 2023
Our finished products were analysed against USP-NF monographs by the ISO/IEC 17025 accredited USP laboratory in Accra, Ghana, and passed LMHRA quality laboratory analysis.
On that basis the LMHRA Inspector General authorised the circulation of our products on the Liberian market. Batch-specific certificates of analysis are available on request.
